Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 21, 2022
Accumulus Synergy, a non-profit organization working to develop an information and data exchange platform aimed at transforming how life science innovators and health authorities worldwide interact, announced that Merck, known as MSD outside the ...
read more
Wednesday, September 21, 2022
WuXi Biologics announced that its two Drug Substance (DS) facilities and a Drug Product (DP) facility located in Wuxi city received regulatory approvals from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).
read more
Wednesday, September 21, 2022
Merck will initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection.
read more
Wednesday, September 21, 2022
Lykan Bioscience named Barbara Ressler, Ph.D. VP of Manufacturing Process Sciences. development, process development and manufacturing science and technology (MS&T) teams.
read more
Wednesday, September 21, 2022
Johnson & Johnson opened its San Francisco Bay Campus, a state-of-the-art Research & Development (R&D) facility in the Bay Area, one of the world’s most established global hubs for innovation and entrepreneurship.
read more
Wednesday, September 21, 2022
Charles River Associates announced that Kenneth J. Beers has joined CRA as a Vice President in the Company’s Life Sciences Practice.
read more
Monday, September 19, 2022
LSPediA Inc., a cloud solutions provider for the pharmaceutical industry, added Patrick O'Donohue to its Leadership Team as Vice President of Operations.
read more
Thursday, September 15, 2022
Immunologix Laboratories announced that Dr. Pierre Jolicoeur has been appointed Chief Operating Officer. A seasoned scientist and trusted operational leader, Dr. Jolicoeur will help drive strategic growth and operational excellence across the company...
read more
Thursday, September 15, 2022
Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company specializing in development and commercialization of niche generic ...
read more
Thursday, September 15, 2022
The development of new drug products and forms of therapy is progressing rapidly. For contract developers and manufacturers, this means staying on the cutting edge of production technologies and actively supporting customers with innovative ...
read more
Thursday, September 15, 2022
The PPD clinical research business of Thermo Fisher Scientific has been awarded a 10-year Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract by the National Cancer Institute (NCI), part of the National Institutes of Health, to support NCI’s ...
read more
Wednesday, September 14, 2022
BioIVT, a provider of biospecimens, research models and services for drug and diagnostic development, has acquired XenoTech, a provider of products for ADME-Tox in vitro models and contract research services, from Sekisui Chemical, based in Japan. ...
read more
Wednesday, September 14, 2022
WCG announced the expansion of its Phase I review services, providing purpose-built operations for Phase I investigators. Launched in conjunction with the opening of Dr. Vince Clinical Research’s (DVCR) industry-leading, green-designed research ...
read more
Wednesday, September 14, 2022
Strata Oncology, Inc. announced expansion of its clinical collaboration with Pfizer in the Strata Precision Indications for Approved THerapies (Strata PATHTM) trial. Strata PATH is a prospective pan-tumor therapeutic trial designed to evaluate the ...
read more
Wednesday, September 14, 2022
Following their recent expansion into formulation, method and lyo development, Berkshire Sterile Manufacturing (BSM) now offers two new services to assist their clients in their R&D efforts as they head towards clinical development and trials.
read more